NCT00945555View on ClinicalTrials.gov

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

CompletedOBSERVATIONAL
Enrollment

264

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Febrile Neutropenia
Interventions
DRUG

Antibacterial agent for the treatment of febrile neutropenia

The antibacterial agent used by the investigators for febrile neutropenia will be determined and classified in the preference order

Trial Locations (5)

Unknown

Pfizer Investigational Site, Kayseri

Pfizer Investigational Site, Kocaeli

Pfizer Investigational Site, Bursa

Pfizer Investigational Site, Istanbul

06500

Pfizer Investigational Site, Ankara

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY